全球骨生长刺激器市场规模、份额、增长分析，按应用（脊柱融合、颌面和牙科）、最终用户（医院和 ASC、专科诊所）- 2024-2031 年行业预测

Global Bone Growth Stimulators Market Size, Share, Growth Analysis, By Application(Spinal Fusion, Maxillofacial & Dental), By End User(Hospitals & ASCs, Specialty Clinics) - Industry Forecast 2024-2031

出版日期: 2024年03月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年，全球骨骼生长刺激剂市场规模为19.3亿美元，预计将从2023年的20.2亿美元成长到2031年的29.7亿美元，预测期间（2024-2031年）复合年增长率为4.9%。

骨生长刺激作为一种补充治疗，已经相当受欢迎，特别是在骨癒合方面。骨刺激器通常用于治疗未自然癒合的骨折。全球骨折和运动相关损伤的发生率不断增加，刺激了对骨生长刺激剂的需求。根据国家脊髓损伤统计中心 (NSCISC) 的资料，美国每年每百万人中约有 54 例脊髓损伤 (SCI)。根据国家生物技术资讯中心报告，全球每年有 25 万至 50 万人遭受脊髓损伤。骨科手术极大地受益于骨生长刺激技术和相关产品的进步。鑑于市场潜力，许多关于骨形态发生蛋白的临床研究已经启动。这些刺激器广泛应用于各个医疗领域，包括脊椎融合、牙科、颚面手术、骨折修復等。由于骨关节炎和退化性骨疾病的日益流行，市场正在进一步扩大。此外，对富含血小板的血浆和骨形态发生蛋白的快速采用和需求预计将透过增强治疗效果来促进市场成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Zimmer Biomet Holdings, Inc. (United States)
Stryker Corporation (United States)
Medtronic plc (Ireland)
Orthofix Medical Inc. (United States)
DJO Global, Inc. (United States)
Bioventus LLC (United States)
DePuy Synthes (a Johnson & Johnson Company) (United States)
Arthrex, Inc. (United States)
Smith & Nephew plc (United Kingdom)
Elizur Corporation (United States)
Isto Biologics (United States)
Ossatec Benelux BV (Netherlands)
Terumo Corporation (Japan)
RTI Surgical Holdings, Inc. (United States)
Bioventus LLC (United States)
Ember Therapeutics (United States)
Isto Biologics (United States)
DePuy Synthes Spine (United States)
Aetna Inc. (United States)
Ossatec Benelux BV (Netherlands)
BONESUPPORT AB (Sweden)
Regen Lab SA (Switzerland)

简介目录

Product Code: SQMIG35A2314

Global bone growth stimulators market size was valued at USD 1.93 billion in 2022 and is poised to grow from USD 2.02 billion in 2023 to USD 2.97 billion by 2031, at a CAGR of 4.9% during the forecast period (2024-2031).

Bone growth stimulation, a supplementary treatment, has gained considerable popularity, especially in the context of bone healing. Bone stimulators are commonly employed for fractures that have not healed naturally. The increasing incidence of bone fractures and sports-related injuries globally is fueling the demand for bone growth stimulators. According to data from the National Spinal Cord Injury Statistical Center (NSCISC), the United States sees approximately 54 cases of spinal cord injury (SCI) per million people each year. Globally, between 250,000 to 500,000 individuals suffer from spinal cord injuries annually, as reported by the National Center for Biotechnology Information. Orthopedic surgeries have greatly benefited from advancements in bone growth stimulation technology and related products. Given the market potential, numerous clinical studies on bone morphogenetic protein have been initiated. These stimulators find widespread use across various medical fields, including spinal fusion, dentistry, maxillofacial procedures, fracture repair, and others. The market is expanding further due to the growing prevalence of osteoarthritis and degenerative bone diseases. Additionally, the rapid adoption and demand for platelet-rich plasma and bone morphogenetic proteins are expected to contribute to market growth by enhancing healing outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the global bone growth stimulators market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone Growth Stimulators Market Segmental Analysis

The global bone growth stimulators market is segmented based on product, application, end user and region. By product, the market is segmented into bone growth stimulation devices, bone morphogenetic proteins, platelet derived growth factor. By end user, the market is segmented into hospitals & ASCS, specialty clinics, home care. By application, the market is segmented into spinal fusion, maxillofacial & dental, nonunion & union bone fractures. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Bone Growth Stimulators Market

The increasing occurrence of orthopedic ailments, including fractures, delayed unions, non-unions, and fractures related to osteoporosis, serves as a major catalyst for the bone growth stimulators market. With the aging population expanding and the frequency of orthopedic conditions on the rise, there is a corresponding escalation in the demand for bone growth stimulators.

Restraints in the Global Bone Growth Stimulators Market

Although bone growth stimulators are generally deemed safe, there are potential side effects and risks linked to their utilization. These may encompass skin irritation, allergic reactions, and discomfort experienced during treatment. Worries regarding potential adverse effects could dissuade certain patients and healthcare practitioners from employing bone growth stimulators.

Market Trends of the Global Bone Growth Stimulators Market

Currently, the bone growth stimulators industry is experiencing notable shifts driven by several significant developments. One prominent trend is the growing demand for treatments that are more patient-friendly and less invasive. Bone growth stimulators are increasingly preferred by healthcare providers and patients alike for their capacity to offer a less invasive option compared to traditional surgical methods, thus promoting bone healing. This trend is particularly evident in the treatment of orthopedic conditions such as spinal fusion, fractures, and others.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Bone Growth Stimulators Market by Application

Market Overview
Spinal Fusion
Maxillofacial & Dental
Nonunion & Union Bone Fractures

Global Bone Growth Stimulators Market by End User

Market Overview
Hospitals & ASCs
Specialty Clinics
Home Care

Global Bone Growth Stimulators Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DJO Global, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DePuy Synthes (a Johnson & Johnson Company) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elizur Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isto Biologics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossatec Benelux B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RTI Surgical Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ember Therapeutics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isto Biologics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DePuy Synthes Spine (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aetna Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossatec Benelux B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BONESUPPORT AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regen Lab SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments